{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:13:25Z","timestamp":1792592005267,"version":"4.5.0"},"reference-count":167,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nucleoporin 98 (NUP98) fusion oncoproteins are observed in a spectrum of hematologic malignancies, particularly pediatric leukemias with poor patient outcomes. Although wild-type full-length NUP98 is a member of the nuclear pore complex, the chromosomal translocations leading to NUP98 gene fusions involve the intrinsically disordered and N-terminal region of NUP98 with over 30 partner genes. Fusion partners include several genes bearing homeodomains or having known roles in transcriptional or epigenetic regulation. Based on data in both experimental models and patient samples, NUP98 fusion oncoprotein\u2013driven leukemogenesis is mediated by changes in chromatin structure and gene expression. Multiple cofactors associate with NUP98 fusion oncoproteins to mediate transcriptional changes possibly via phase separation, in a manner likely dependent on the fusion partner. NUP98 gene fusions co-occur with a set of additional mutations, including FLT3\u2013internal tandem duplication and other events contributing to increased proliferation. To improve the currently dire outcomes for patients with NUP98-rearranged malignancies, therapeutic strategies have been considered that target transcriptional and epigenetic machinery, cooperating alterations, and signaling or cell-cycle pathways. With the development of more faithful experimental systems and continued study, we anticipate great strides in our understanding of the molecular mechanisms and therapeutic vulnerabilities at play in NUP98-rearranged models. Taken together, these studies should lead to improved clinical outcomes for NUP98-rearranged leukemia.<\/jats:p>","DOI":"10.1182\/blood.2020007093","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T17:06:25Z","timestamp":1596819985000},"page":"2275-2289","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":159,"title":["Mechanistic insights and potential therapeutic approaches for\n                    <i>NUP98<\/i>\n                    -rearranged hematologic malignancies"],"prefix":"10.1182","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9960-5119","authenticated-orcid":false,"given":"Nicole L.","family":"Michmerhuizen","sequence":"first","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2961-6960","authenticated-orcid":false,"given":"Jeffery M.","family":"Klco","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1850","authenticated-orcid":false,"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"16","key":"2020120315415867500_B1","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1200\/JCO.2009.24.8997","article-title":"Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12","volume":"28","author":"Harrison","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"2020120315415867500_B2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41375-019-0546-1","article-title":"Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing","volume":"34","author":"Kim","year":"2020","journal-title":"Leukemia"},{"issue":"4","key":"2020120315415867500_B3","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41588-019-0375-1","article-title":"Genomic subtyping and therapeutic targeting of acute erythroleukemia","volume":"51","author":"Iacobucci","year":"2019","journal-title":"Nat Genet"},{"issue":"1","key":"2020120315415867500_B4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nm.4439","article-title":"The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions [published corrections appear in Nat Med. 2018;24(4):526 and Nat Med. 2019;25(3):530]","volume":"24","author":"Bolouri","year":"2018","journal-title":"Nat Med"},{"key":"2020120315415867500_B5","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1038\/ncomms13331","article-title":"Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia","volume":"7","author":"Gu","year":"2016","journal-title":"Nat Commun"},{"issue":"6","key":"2020120315415867500_B6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrclinonc.2015.38","article-title":"Genomics in acute lymphoblastic leukaemia: insights and treatment implications","volume":"12","author":"Roberts","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"14","key":"2020120315415867500_B7","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"issue":"14","key":"2020120315415867500_B8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"issue":"9","key":"2020120315415867500_B9","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1091\/mbc.e04-03-0165","article-title":"Nucleoporins as components of the nuclear pore complex core structure and Tpr as the architectural element of the nuclear basket","volume":"15","author":"Krull","year":"2004","journal-title":"Mol Biol Cell"},{"issue":"1","key":"2020120315415867500_B10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jsb.2011.11.004","article-title":"Domain topology of nucleoporin Nup98 within the nuclear pore complex","volume":"177","author":"Chatel","year":"2012","journal-title":"J Struct Biol"},{"issue":"20","key":"2020120315415867500_B11","doi-asserted-by":"crossref","first-page":"11370","DOI":"10.1073\/pnas.96.20.11370","article-title":"Autoproteolysis in nucleoporin biogenesis","volume":"96","author":"Rosenblum","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2020120315415867500_B12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cell.2009.12.054","article-title":"Chromatin-bound nuclear pore components regulate gene expression in higher eukaryotes","volume":"140","author":"Capelson","year":"2010","journal-title":"Cell"},{"issue":"4","key":"2020120315415867500_B13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cell.2011.01.012","article-title":"Phosphorylation of Nup98 by multiple kinases is crucial for NPC disassembly during mitotic entry","volume":"144","author":"Laurell","year":"2011","journal-title":"Cell"},{"issue":"3","key":"2020120315415867500_B14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cell.2010.01.011","article-title":"Nucleoporins directly stimulate expression of developmental and cell-cycle genes inside the nucleoplasm","volume":"140","author":"Kalverda","year":"2010","journal-title":"Cell"},{"issue":"2","key":"2020120315415867500_B15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0092-8674(95)90331-3","article-title":"The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex","volume":"81","author":"Radu","year":"1995","journal-title":"Cell"},{"issue":"4","key":"2020120315415867500_B16","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1091\/mbc.01-11-0538","article-title":"Nup98 is a mobile nucleoporin with transcription-dependent dynamics","volume":"13","author":"Griffis","year":"2002","journal-title":"Mol Biol Cell"},{"issue":"11","key":"2020120315415867500_B17","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1091\/mbc.e09-12-1041","article-title":"The mobile FG nucleoporin Nup98 is a cofactor for Crm1-dependent protein export","volume":"21","author":"Oka","year":"2010","journal-title":"Mol Biol Cell"},{"issue":"23","key":"2020120315415867500_B18","doi-asserted-by":"crossref","first-page":"20979","DOI":"10.1074\/jbc.M302061200","article-title":"Complex formation among the RNA export proteins Nup98, Rae1\/Gle2, and TAP","volume":"278","author":"Blevins","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"2020120315415867500_B19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1083\/jcb.145.2.237","article-title":"RAE1 is a shuttling mRNA export factor that binds to a GLEBS-like NUP98 motif at the nuclear pore complex through multiple domains","volume":"145","author":"Pritchard","year":"1999","journal-title":"J Cell Biol"},{"issue":"2","key":"2020120315415867500_B20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng0296-154","article-title":"Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia","volume":"12","author":"Nakamura","year":"1996","journal-title":"Nat Genet"},{"issue":"2","key":"2020120315415867500_B21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ng0296-159","article-title":"The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9","volume":"12","author":"Borrow","year":"1996","journal-title":"Nat Genet"},{"issue":"11","key":"2020120315415867500_B22","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1182\/blood.V89.11.3936","article-title":"The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10","volume":"89","author":"Arai","year":"1997","journal-title":"Blood"},{"issue":"3","key":"2020120315415867500_B23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<215::AID-GCC5>3.0.CO;2-1","article-title":"11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia\/myelodysplastic syndrome","volume":"26","author":"Nishiyama","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"2020120315415867500_B24","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood.V99.4.1428","article-title":"Single-translocation and double-chimeric transcripts: detection of NUP98-HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15)","volume":"99","author":"Fujino","year":"2002","journal-title":"Blood"},{"issue":"2","key":"2020120315415867500_B25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2141.2000.02003.x","article-title":"Expression of the NUP98\/HOXA9 fusion transcript in the blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia with t(7;11)(p15;p15)","volume":"109","author":"Yamamoto","year":"2000","journal-title":"Br J Haematol"},{"issue":"6","key":"2020120315415867500_B26","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1182\/blood.V94.6.2072","article-title":"The (4;11)(q21;p15) translocation fuses the NUP98 and RAP1GDS1 genes and is recurrent in T-cell acute lymphocytic leukemia","volume":"94","author":"Hussey","year":"1999","journal-title":"Blood"},{"issue":"2","key":"2020120315415867500_B27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2141.2006.06410.x","article-title":"Fusion of NUP98 and the SET binding protein 1 (SETBP1) gene in a paediatric acute T cell lymphoblastic leukaemia with t(11;18)(p15;q12)","volume":"136","author":"Panagopoulos","year":"2007","journal-title":"Br J Haematol"},{"issue":"4","key":"2020120315415867500_B28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/sj.leu.2404130","article-title":"NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique","volume":"20","author":"Romana","year":"2006","journal-title":"Leukemia"},{"issue":"24","key":"2020120315415867500_B29","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1038\/sj.onc.1210999","article-title":"A new fusion gene NUP98-IQCG identified in an acute T-lymphoid\/myeloid leukemia with a t(3;11)(q29q13;p15)del(3)(q29) translocation","volume":"27","author":"Pan","year":"2008","journal-title":"Oncogene"},{"issue":"7696","key":"2020120315415867500_B30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature25795","article-title":"Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours","volume":"555","author":"Ma","year":"2018","journal-title":"Nature"},{"issue":"3","key":"2020120315415867500_B31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/leu.2016.267","article-title":"NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis","volume":"31","author":"Struski","year":"2017","journal-title":"Leukemia"},{"key":"2020120315415867500_B32","doi-asserted-by":"crossref","first-page":"1609128","DOI":"10.1155\/2019\/1609128","article-title":"Mutated WT1, FLT3-ITD, and NUP98-NSD1 fusion in various combinations define a poor prognostic group in pediatric acute myeloid leukemia","volume":"2019","author":"Niktoreh","year":"2019","journal-title":"J Oncol"},{"issue":"4","key":"2020120315415867500_B33","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/leu.2016.361","article-title":"NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group","volume":"31","author":"Bisio","year":"2017","journal-title":"Leukemia"},{"issue":"13","key":"2020120315415867500_B34","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1182\/blood-2011-04-346643","article-title":"NUP98\/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern","volume":"118","author":"Hollink","year":"2011","journal-title":"Blood"},{"issue":"16","key":"2020120315415867500_B35","first-page":"4571","article-title":"Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13)","volume":"62","author":"Taketani","year":"2002","journal-title":"Cancer Res"},{"issue":"4","key":"2020120315415867500_B36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/gcc.10182","article-title":"Human homeobox gene HOXC13 is the partner of NUP98 in adult acute myeloid leukemia with t(11;12)(p15;q13)","volume":"36","author":"La Starza","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"2020120315415867500_B37","first-page":"33","article-title":"The HOXD11 gene is fused to the NUP98 gene in acute myeloid leukemia with t(2;11)(q31;p15)","volume":"62","author":"Taketani","year":"2002","journal-title":"Cancer Res"},{"issue":"19","key":"2020120315415867500_B38","first-page":"4269","article-title":"NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia","volume":"58","author":"Raza-Egilmez","year":"1998","journal-title":"Cancer Res"},{"issue":"12","key":"2020120315415867500_B39","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1182\/blood-2007-09-108175","article-title":"Leukemogenic mechanisms and targets of a NUP98\/HHEX fusion in acute myeloid leukemia","volume":"111","author":"Jankovic","year":"2008","journal-title":"Blood"},{"issue":"7","key":"2020120315415867500_B40","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1038\/bcj.2013.20","article-title":"Identification of GSX2 and AF10 as NUP98 partner genes in myeloid malignancies [letter]","volume":"3","author":"Soler","year":"2013","journal-title":"Blood Cancer J"},{"issue":"2","key":"2020120315415867500_B41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1182\/blood.V94.2.741","article-title":"NUP98 is fused to PMX1 homeobox gene in human acute myelogenous leukemia with chromosome translocation t(1;11)(q23;p15)","volume":"94","author":"Nakamura","year":"1999","journal-title":"Blood"},{"issue":"1","key":"2020120315415867500_B42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.leu.2403565","article-title":"A new translocation t(9;11)(q34;p15) fuses NUP98 to a novel homeobox partner gene, PRRX2, in a therapy-related acute myeloid leukemia","volume":"19","author":"Gervais","year":"2005","journal-title":"Leukemia"},{"key":"2020120315415867500_B43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-12-5","article-title":"POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15)","volume":"12","author":"Lisboa","year":"2013","journal-title":"Mol Cancer"},{"issue":"3","key":"2020120315415867500_B44","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood.V99.3.1097","article-title":"Recurrent coiled-coil motifs in NUP98 fusion partners provide a clue to leukemogenesis","volume":"99","author":"Hussey","year":"2002","journal-title":"Blood"},{"issue":"6","key":"2020120315415867500_B45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/gcc.22532","article-title":"NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy","volume":"57","author":"Roussy","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"2020120315415867500_B46","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41467-017-01590-5","article-title":"The genomic landscape of pediatric myelodysplastic syndromes","volume":"8","author":"Schwartz","year":"2017","journal-title":"Nat Commun"},{"issue":"5","key":"2020120315415867500_B47","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/gcc.20308","article-title":"Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene","volume":"45","author":"van Zutven","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"2020120315415867500_B48","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood.V98.4.1264","article-title":"A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia","volume":"98","author":"Jaju","year":"2001","journal-title":"Blood"},{"issue":"10","key":"2020120315415867500_B49","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood.V99.10.3857","article-title":"NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15)","volume":"99","author":"Rosati","year":"2002","journal-title":"Blood"},{"issue":"4","key":"2020120315415867500_B50","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.leu.2404579","article-title":"A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia","volume":"21","author":"Reader","year":"2007","journal-title":"Leukemia"},{"issue":"13","key":"2020120315415867500_B51","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2010-04-277806","article-title":"NUP98-MLL fusion in human acute myeloblastic leukemia","volume":"116","author":"Kaltenbach","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2020120315415867500_B52","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1182\/bloodadvances.2018025007","article-title":"NUP98-HBO1-fusion generates phenotypically and genetically relevant chronic myelomonocytic leukemia pathogenesis","volume":"3","author":"Hayashi","year":"2019","journal-title":"Blood Adv"},{"issue":"22","key":"2020120315415867500_B53","first-page":"6227","article-title":"t(9;11)(p22;p15) in acute myeloid leukemia results in a fusion between NUP98 and the gene encoding transcriptional coactivators p52 and p75-lens epithelium-derived growth factor (LEDGF)","volume":"60","author":"Ahuja","year":"2000","journal-title":"Cancer Res"},{"issue":"12","key":"2020120315415867500_B54","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/leu.2013.87","article-title":"NUP98\/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern","volume":"27","author":"de Rooij","year":"2013","journal-title":"Leukemia"},{"key":"2020120315415867500_B55","article-title":"The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia [published online ahead of print 7 May 2020]","author":"Noort","journal-title":"Haematologica"},{"issue":"4","key":"2020120315415867500_B56","first-page":"436","article-title":"Molecular evaluation of the NUP98\/RAP1GDS1 gene frequency in adults with T-acute lymphoblastic leukemia","volume":"86","author":"Cimino","year":"2001","journal-title":"Haematologica"},{"issue":"3","key":"2020120315415867500_B57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/gcc.10119","article-title":"Cryptic translocation t(5;11)(q35;p15.5) with involvement of the NSD1 and NUP98 genes without 5q deletion in childhood acute myeloid leukemia","volume":"35","author":"Panarello","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2020120315415867500_B58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cancergencyto.2009.03.007","article-title":"Acute myeloid leukemia with NUP98-HOXC13 fusion and FLT3 internal tandem duplication mutation: case report and literature review","volume":"193","author":"Tosi\u0107","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"issue":"7","key":"2020120315415867500_B59","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/gcc.22064","article-title":"NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia","volume":"52","author":"Shiba","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"2020120315415867500_B60","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/HS9.0000000000000031","article-title":"Molecular profiling defines distinct prognostic subgroups in childhood AML: a report from the French ELAM02 Study Group","volume":"2","author":"Marceau-Renaut","year":"2018","journal-title":"HemaSphere"},{"issue":"4","key":"2020120315415867500_B61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bjh.16203","article-title":"Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup","volume":"188","author":"Hara","year":"2020","journal-title":"Br J Haematol"},{"issue":"3","key":"2020120315415867500_B62","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.3772","article-title":"Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes","volume":"49","author":"de Rooij","year":"2017","journal-title":"Nat Genet"},{"issue":"26","key":"2020120315415867500_B63","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1182\/blood-2016-01-695551","article-title":"Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study","volume":"127","author":"de Rooij","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2020120315415867500_B64","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s12185-017-2395-x","article-title":"Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study","volume":"107","author":"Shimada","year":"2018","journal-title":"Int J Hematol"},{"issue":"9","key":"2020120315415867500_B65","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.leukres.2013.05.020","article-title":"Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocation","volume":"37","author":"Wei","year":"2013","journal-title":"Leuk Res"},{"issue":"7","key":"2020120315415867500_B66","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/leu.2009.25","article-title":"Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients","volume":"23","author":"Chou","year":"2009","journal-title":"Leukemia"},{"issue":"1","key":"2020120315415867500_B67","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/leu.2012.230","article-title":"A rare but specific subset of adult AML patients can be defined by the cytogenetically cryptic NUP98-NSD1 fusion gene","volume":"27","author":"Fasan","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"2020120315415867500_B68","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/leu.2012.249","article-title":"Analysis of NUP98\/NSD1 translocations in adult AML and MDS patients","volume":"27","author":"Thol","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"2020120315415867500_B69","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/bjh.15799","article-title":"Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia\/Lymphoma Study Group AML-05 study","volume":"185","author":"Miyamura","year":"2019","journal-title":"Br J Haematol"},{"issue":"15","key":"2020120315415867500_B70","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1182\/blood-2014-04-570929","article-title":"NUP98\/NSD1 and FLT3\/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report","volume":"124","author":"Ostronoff","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2020120315415867500_B71","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1038\/s41375-019-0402-3","article-title":"Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia","volume":"33","author":"McNeer","year":"2019","journal-title":"Leukemia"},{"issue":"3","key":"2020120315415867500_B72","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/emboj\/20.3.350","article-title":"NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice","volume":"20","author":"Kroon","year":"2001","journal-title":"EMBO J"},{"issue":"11","key":"2020120315415867500_B73","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1182\/blood-2002-08-2484","article-title":"Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1","volume":"101","author":"Pineault","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2020120315415867500_B74","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1182\/blood-2003-10-3550","article-title":"NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation","volume":"104","author":"Gurevich","year":"2004","journal-title":"Blood"},{"issue":"5","key":"2020120315415867500_B75","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/MCB.24.5.1907-1917.2004","article-title":"Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1","volume":"24","author":"Pineault","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"7","key":"2020120315415867500_B76","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ncb1608","article-title":"NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis","volume":"9","author":"Wang","year":"2007","journal-title":"Nat Cell Biol"},{"issue":"7248","key":"2020120315415867500_B77","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature08036","article-title":"Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger","volume":"459","author":"Wang","year":"2009","journal-title":"Nature"},{"issue":"46","key":"2020120315415867500_B78","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1038\/onc.2008.210","article-title":"Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor","volume":"27","author":"Hirose","year":"2008","journal-title":"Oncogene"},{"issue":"3","key":"2020120315415867500_B79","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/leu.2009.241","article-title":"NUP98-HMGB3: a novel oncogenic fusion","volume":"24","author":"Petit","year":"2010","journal-title":"Leukemia"},{"issue":"3","key":"2020120315415867500_B80","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3324\/haematol.2011.047969","article-title":"Functional analysis of the NUP98-CCDC28A fusion protein","volume":"97","author":"Petit","year":"2012","journal-title":"Haematologica"},{"issue":"7","key":"2020120315415867500_B81","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/leu.2015.347","article-title":"Human NUP98-IQCG fusion protein induces acute myelomonocytic leukemia in mice by dysregulating the Hox\/Pbx3 pathway","volume":"30","author":"Pan","year":"2016","journal-title":"Leukemia"},{"issue":"2","key":"2020120315415867500_B82","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood-2004-04-1508","article-title":"Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model","volume":"105","author":"Iwasaki","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2020120315415867500_B83","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2004-12-4794","article-title":"NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia","volume":"106","author":"Lin","year":"2005","journal-title":"Blood"},{"issue":"12","key":"2020120315415867500_B84","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.leukres.2013.09.013","article-title":"The fusion partner specifies the oncogenic potential of NUP98 fusion proteins","volume":"37","author":"Saw","year":"2013","journal-title":"Leuk Res"},{"issue":"5","key":"2020120315415867500_B85","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1158\/2159-8290.CD-13-0419","article-title":"NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function","volume":"4","author":"Gough","year":"2014","journal-title":"Cancer Discov"},{"issue":"7","key":"2020120315415867500_B86","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3324\/haematol.2019.219188","article-title":"Transforming activities of the NUP98-KMT2A fusion gene associated with myelodysplasia and acute myeloid leukemia","volume":"105","author":"Fisher","year":"2020","journal-title":"Haematologica"},{"issue":"24","key":"2020120315415867500_B87","doi-asserted-by":"crossref","first-page":"11781","DOI":"10.1158\/0008-5472.CAN-06-0706","article-title":"Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation","volume":"66","author":"Chung","year":"2006","journal-title":"Cancer Res"},{"issue":"24","key":"2020120315415867500_B88","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1182\/blood-2014-04-564666","article-title":"Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13","volume":"124","author":"Imren","year":"2014","journal-title":"Blood"},{"issue":"21","key":"2020120315415867500_B89","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1182\/bloodadvances.2019030981","article-title":"Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities","volume":"3","author":"Cardin","year":"2019","journal-title":"Blood Adv"},{"issue":"11","key":"2020120315415867500_B90","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1084\/jem.20121343","article-title":"Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models","volume":"209","author":"Thiollier","year":"2012","journal-title":"J Exp Med"},{"issue":"27","key":"2020120315415867500_B91","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1038\/sj.onc.1205516","article-title":"Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1","volume":"21","author":"Calvo","year":"2002","journal-title":"Oncogene"},{"issue":"2","key":"2020120315415867500_B92","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1074\/jbc.M307280200","article-title":"The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells","volume":"279","author":"Ghannam","year":"2004","journal-title":"J Biol Chem"},{"issue":"4","key":"2020120315415867500_B93","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.2019003267","article-title":"CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia","volume":"136","author":"Schmoellerl","year":"2020","journal-title":"Blood"},{"issue":"7","key":"2020120315415867500_B94","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cell.2018.10.042","article-title":"Transcription factors activate genes through the phase-separation capacity of their activation domains","volume":"175","author":"Boija","year":"2018","journal-title":"Cell"},{"key":"2020120315415867500_B95","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7554\/eLife.04251","article-title":"Nup98 FG domains from diverse species spontaneously phase-separate into particles with nuclear pore-like permselectivity","volume":"4","author":"Schmidt","year":"2015","journal-title":"eLife"},{"issue":"1","key":"2020120315415867500_B96","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/MCB.19.1.764","article-title":"CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity","volume":"19","author":"Kasper","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"3","key":"2020120315415867500_B97","doi-asserted-by":"crossref","first-page":"e0152321","DOI":"10.1371\/journal.pone.0152321","article-title":"Expression of leukemia-associated Nup98 fusion proteins generates an aberrant nuclear envelope phenotype","volume":"11","author":"Fahrenkrog","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"2020120315415867500_B98","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/leu.2016.347","article-title":"Loss of p300 accelerates MDS-associated leukemogenesis","volume":"31","author":"Cheng","year":"2017","journal-title":"Leukemia"},{"issue":"9","key":"2020120315415867500_B99","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/leu.2017.194","article-title":"The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia","volume":"31","author":"Rio-Machin","year":"2017","journal-title":"Leukemia"},{"issue":"4","key":"2020120315415867500_B100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.leukres.2010.10.006","article-title":"Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions","volume":"35","author":"Yung","year":"2011","journal-title":"Leuk Res"},{"issue":"4","key":"2020120315415867500_B101","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/sj.leu.2403696","article-title":"Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA","volume":"19","author":"Pineault","year":"2005","journal-title":"Leukemia"},{"issue":"7","key":"2020120315415867500_B102","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.exphem.2008.02.011","article-title":"Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3","volume":"36","author":"Argiropoulos","year":"2008","journal-title":"Exp Hematol"},{"issue":"9","key":"2020120315415867500_B103","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1038\/bcj.2017.86","article-title":"Meis2 as a critical player in MN1-induced leukemia","volume":"7","author":"Lai","year":"2017","journal-title":"Blood Cancer J"},{"issue":"2","key":"2020120315415867500_B104","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.celrep.2016.05.094","article-title":"MEIS2 is an oncogenic partner in AML1-ETO-positive AML","volume":"16","author":"Vegi","year":"2016","journal-title":"Cell Rep"},{"issue":"22","key":"2020120315415867500_B105","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1101\/gad.306753.117","article-title":"Nup98 recruits the Wdr82-Set1A\/COMPASS complex to promoters to regulate H3K4 trimethylation in hematopoietic progenitor cells","volume":"31","author":"Franks","year":"2017","journal-title":"Genes Dev"},{"issue":"6","key":"2020120315415867500_B106","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ccell.2016.10.019","article-title":"NUP98 fusion proteins interact with the NSL and MLL1 complexes to drive leukemogenesis","volume":"30","author":"Xu","year":"2016","journal-title":"Cancer Cell"},{"issue":"7","key":"2020120315415867500_B107","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1158\/0008-5472.CAN-16-2374","article-title":"Histone acetyltransferase activity of MOF is required for MLL-AF9 leukemogenesis","volume":"77","author":"Valerio","year":"2017","journal-title":"Cancer Res"},{"issue":"21","key":"2020120315415867500_B108","doi-asserted-by":"crossref","first-page":"16248","DOI":"10.1074\/jbc.M109.048785","article-title":"Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins","volume":"285","author":"Takeda","year":"2010","journal-title":"J Biol Chem"},{"key":"2020120315415867500_B109","doi-asserted-by":"crossref","first-page":"e09540","DOI":"10.7554\/eLife.09540","article-title":"Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes","volume":"5","author":"Oka","year":"2016","journal-title":"eLife"},{"issue":"17","key":"2020120315415867500_B110","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1080\/15384101.2016.1172156","article-title":"NUP98 fusion oncoproteins interact with the APC\/C(Cdc20) as a pseudosubstrate and prevent mitotic checkpoint complex binding","volume":"15","author":"Salsi","year":"2016","journal-title":"Cell Cycle"},{"issue":"4","key":"2020120315415867500_B111","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-13-0912","article-title":"NUP98 fusion oncoproteins promote aneuploidy by attenuating the mitotic spindle checkpoint","volume":"74","author":"Salsi","year":"2014","journal-title":"Cancer Res"},{"issue":"1","key":"2020120315415867500_B112","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.leukres.2012.10.012","article-title":"Non-homologous end joining mediated DNA repair is impaired in the NUP98-HOXD13 mouse model for myelodysplastic syndrome","volume":"37","author":"Puthiyaveetil","year":"2013","journal-title":"Leuk Res"},{"issue":"12","key":"2020120315415867500_B113","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2012-05-430736","article-title":"Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome","volume":"120","author":"Slape","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2020120315415867500_B114","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/cdd.2015.159","article-title":"PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia","volume":"23","author":"Guirguis","year":"2016","journal-title":"Cell Death Differ"},{"issue":"5","key":"2020120315415867500_B115","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/stem.1635","article-title":"Brief report: Loss of p15Ink4b accelerates development of myeloid neoplasms in Nup98-HoxD13 transgenic mice","volume":"32","author":"Humeniuk","year":"2014","journal-title":"Stem Cells"},{"issue":"8","key":"2020120315415867500_B116","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1242\/dmm.015974","article-title":"Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?","volume":"7","author":"Grove","year":"2014","journal-title":"Dis Model Mech"},{"issue":"8","key":"2020120315415867500_B117","doi-asserted-by":"crossref","first-page":"e12464","DOI":"10.1371\/journal.pone.0012464","article-title":"In vitro transformation of primary human CD34+ cells by AML fusion oncogenes: early gene expression profiling reveals possible drug target in AML","volume":"5","author":"Abdul-Nabi","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"2020120315415867500_B118","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3324\/haematol.2013.100917","article-title":"Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction","volume":"99","author":"Thanasopoulou","year":"2014","journal-title":"Haematologica"},{"issue":"12","key":"2020120315415867500_B119","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1182\/blood-2011-10-382283","article-title":"Knock-in of a FLT3\/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model","volume":"119","author":"Greenblatt","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2020120315415867500_B120","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/leu.2017.62","article-title":"MLL is essential for NUP98-HOXA9-induced leukemia","volume":"31","author":"Shima","year":"2017","journal-title":"Leukemia"},{"issue":"11","key":"2020120315415867500_B121","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/gcc.22100","article-title":"NUP98-NSD1 fusion in association with FLT3-ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR","volume":"52","author":"Akiki","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"2020120315415867500_B122","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1073\/pnas.102583199","article-title":"A murine model of CML blast crisis induced by cooperation between BCR\/ABL and NUP98\/HOXA9","volume":"99","author":"Dash","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2020120315415867500_B123","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.leukres.2015.04.014","article-title":"NUP98\/11p15 translocations affect CD34+ cells in myeloid and T lymphoid leukemias","volume":"39","author":"Crescenzi","year":"2015","journal-title":"Leuk Res"},{"issue":"6","key":"2020120315415867500_B124","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood-2005-07-3013","article-title":"Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia\/lymphoma","volume":"107","author":"Lin","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2020120315415867500_B125","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.trecan.2017.07.003","article-title":"Pediatric acute megakaryoblastic leukemia: multitasking fusion proteins and oncogenic cooperations","volume":"3","author":"Lopez","year":"2017","journal-title":"Trends Cancer"},{"issue":"6","key":"2020120315415867500_B126","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.molcel.2005.05.012","article-title":"Binding of pRB to the PHD protein RBP2 promotes cellular differentiation","volume":"18","author":"Benevolenskaya","year":"2005","journal-title":"Mol Cell"},{"issue":"33","key":"2020120315415867500_B127","doi-asserted-by":"crossref","first-page":"13379","DOI":"10.1073\/pnas.1110104108","article-title":"Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1","volume":"108","author":"Lin","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6332","key":"2020120315415867500_B128","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/352251a0","article-title":"Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product","volume":"352","author":"Defeo-Jones","year":"1991","journal-title":"Nature"},{"issue":"11","key":"2020120315415867500_B129","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/leu.2010.207","article-title":"High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes","volume":"24","author":"Taketani","year":"2010","journal-title":"Leukemia"},{"issue":"5","key":"2020120315415867500_B130","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.3892\/ol.2017.5823","article-title":"Chromosome t(7;11)(p15;p15) translocation in acute myeloid leukemia coexisting with multilineage dyspoiesis and mutations in NRAS and WT1: A case report and literature review","volume":"13","author":"Yang","year":"2017","journal-title":"Oncol Lett"},{"issue":"7","key":"2020120315415867500_B131","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/leu.2016.19","article-title":"Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations","volume":"30","author":"Lavall\u00e9e","year":"2016","journal-title":"Leukemia"},{"issue":"9","key":"2020120315415867500_B132","doi-asserted-by":"crossref","first-page":"E951","DOI":"10.3390\/cells8090951","article-title":"Synergy of NUP98-HOXA10 fusion gene and NrasG12D mutation preserves the stemness of hematopoietic stem cells on culture condition","volume":"8","author":"Dong","year":"2019","journal-title":"Cells"},{"issue":"5","key":"2020120315415867500_B133","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1182\/blood-2008-01-135186","article-title":"Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl","volume":"112","author":"Slape","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2020120315415867500_B134","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2141.2003.04052.x","article-title":"Successful treatment of acute myelomonocytic leukaemia with NUP98-HOXD11 fusion transcripts and monitoring of minimal residual disease","volume":"120","author":"Terui","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"2020120315415867500_B135","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0609.2011.01736.x","article-title":"Expression of the novel NUP98\/PSIP1 fusion transcripts in myelodysplastic syndrome with t(9;11)(p22;p15)","volume":"88","author":"Yamamoto","year":"2012","journal-title":"Eur J Haematol"},{"key":"2020120315415867500_B136","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cancergen.2019.08.005","article-title":"Rapid detection of chromosomal translocation and precise breakpoint characterization in acute myeloid leukemia by nanopore long-read sequencing","volume":"239","author":"Au","year":"2019","journal-title":"Cancer Genet"},{"issue":"8","key":"2020120315415867500_B137","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa1903455","article-title":"Oral selinexor-dexamethasone for triple-class refractory multiple myeloma","volume":"381","author":"Chari","year":"2019","journal-title":"N Engl J Med"},{"issue":"34","key":"2020120315415867500_B138","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1200\/JCO.2016.67.5066","article-title":"Phase I study of selinexor, a selective inhibitor of nuclear export, in combination with fludarabine and cytarabine, in pediatric relapsed or refractory acute leukemia","volume":"34","author":"Alexander","year":"2016","journal-title":"J Clin Oncol"},{"key":"2020120315415867500_B139","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/sci.2019.02.03","article-title":"The past, present, and future of CRM1\/XPO1 inhibitors","volume":"6","author":"Wang","year":"2019","journal-title":"Stem Cell Investig"},{"issue":"3","key":"2020120315415867500_B140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/onc.2015.92","article-title":"The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia","volume":"35","author":"Giotopoulos","year":"2016","journal-title":"Oncogene"},{"issue":"6","key":"2020120315415867500_B141","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ccell.2014.10.009","article-title":"AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes","volume":"26","author":"Deshpande","year":"2014","journal-title":"Cancer Cell"},{"issue":"6","key":"2020120315415867500_B142","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccell.2019.11.001","article-title":"A menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia","volume":"36","author":"Krivtsov","year":"2019","journal-title":"Cancer Cell"},{"issue":"24","key":"2020120315415867500_B143","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2017-12-818948","article-title":"The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia","volume":"131","author":"Stein","year":"2018","journal-title":"Blood"},{"issue":"42","key":"2020120315415867500_B144","doi-asserted-by":"crossref","first-page":"26603","DOI":"10.18632\/oncotarget.23402","article-title":"p300 suppresses leukemia development in NUP98-HOXD13 driven myelodysplastic syndrome","volume":"9","author":"Man","year":"2018","journal-title":"Oncotarget"},{"issue":"26","key":"2020120315415867500_B145","doi-asserted-by":"crossref","first-page":"39931","DOI":"10.18632\/oncotarget.9539","article-title":"Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance","volume":"7","author":"Gale","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"2020120315415867500_B146","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ccell.2018.10.014","article-title":"KDM5 histone demethylase activity links cellular transcriptomic heterogeneity to therapeutic resistance [published correction appears in Cancer Cell. 2019;35(2):330-332]","volume":"34","author":"Hinohara","year":"2018","journal-title":"Cancer Cell"},{"issue":"5","key":"2020120315415867500_B147","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa1614359","article-title":"Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"issue":"18","key":"2020120315415867500_B148","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1902688","article-title":"Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML","volume":"381","author":"Perl","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"2020120315415867500_B149","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41375-018-0327-2","article-title":"Dasatinib and navitoclax act synergistically to target NUP98-NSD1+\/FLT3-ITD+ acute myeloid leukemia","volume":"33","author":"Kivioja","year":"2019","journal-title":"Leukemia"},{"issue":"15","key":"2020120315415867500_B150","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1182\/blood-2014-09-597690","article-title":"Concealed dagger in FLT3\/ITD+ AML","volume":"124","author":"Ofran","year":"2014","journal-title":"Blood"},{"issue":"24","key":"2020120315415867500_B151","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1182\/blood.2018864173","article-title":"Engineered Bcor mutations lead to acute leukemia of progenitor B-1 lymphocyte origin in a sensitized background","volume":"133","author":"Yin","year":"2019","journal-title":"Blood"},{"issue":"12","key":"2020120315415867500_B152","first-page":"3079","article-title":"NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15)","volume":"63","author":"Lahortiga","year":"2003","journal-title":"Cancer Res"},{"issue":"3","key":"2020120315415867500_B153","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF03006927","article-title":"A novel gene, ANKRD28 on 3p25, is fused with NUP98 on 11p15 in a cryptic 3-way translocation of t(3;5;11)(p25;q35;p15) in an adult patient with myelodysplastic syndrome\/acute myelogenous leukemia","volume":"86","author":"Ishikawa","year":"2007","journal-title":"Int J Hematol"},{"issue":"3","key":"2020120315415867500_B154","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/gcc.20233","article-title":"Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia","volume":"44","author":"Tosi","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"2020120315415867500_B155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/gcc.10139","article-title":"Fusion of the NUP98 gene and the homeobox gene HOXC13 in acute myeloid leukemia with t(11;12)(p15;q13)","volume":"36","author":"Panagopoulos","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"2020120315415867500_B156","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3324\/haematol.12945","article-title":"t(3;11)(q12;p15)\/NUP98-LOC348801 fusion transcript in acute myeloid leukemia","volume":"93","author":"Gorello","year":"2008","journal-title":"Haematologica"},{"issue":"7","key":"2020120315415867500_B157","doi-asserted-by":"crossref","first-page":"E184","DOI":"10.1002\/ajh.25807","article-title":"Identification of a novel NUP98-RARA fusion transcript as the 14th variant of acute promyelocytic leukemia","volume":"95","author":"Zhu","year":"2020","journal-title":"Am J Hematol"},{"issue":"1","key":"2020120315415867500_B158","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood-2010-06-291658","article-title":"A novel NUP98\/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia","volume":"117","author":"Such","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2020120315415867500_B159","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1182\/blood.V94.9.3258","article-title":"The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion","volume":"94","author":"Ahuja","year":"1999","journal-title":"Blood"},{"issue":"18","key":"2020120315415867500_B160","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1158\/1078-0432.CCR-05-0150","article-title":"NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15)","volume":"11","author":"Nebral","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2020120315415867500_B161","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1073\/pnas.1717125115","article-title":"Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020120315415867500_B162","unstructured":"St. Jude Children\u2019s Research Hospital . PROPEL: public resource of patient-derived and expanded leukemias.www.stjude.org\/PROPEL. Accessed 20 August 2020."},{"issue":"4","key":"2020120315415867500_B163","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/cam4.2051","article-title":"Long-term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98-LEDGF rearrangement","volume":"8","author":"Gallego Hernanz","year":"2019","journal-title":"Cancer Med"},{"key":"2020120315415867500_B164","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.leukres.2018.12.009","article-title":"A novel entity of acute myeloid leukaemia with recurrent RARG-rearrangement resembling acute promyelocytic leukaemia","volume":"77","author":"Luo","year":"2019","journal-title":"Leuk Res"},{"issue":"2","key":"2020120315415867500_B165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cancergencyto.2004.06.014","article-title":"Clonal evolution with inv(11)(p15q22) and NUP98\/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemia","volume":"157","author":"Yamamoto","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"2020120315415867500_B166","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/10428194.2015.1037755","article-title":"A unique acute myeloid leukemia patient with cryptic NUP98-NSD1 gene and ASXL1 mutation","volume":"57","author":"Cui","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2020120315415867500_B167","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1365-2141.2000.02106.x","article-title":"t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia","volume":"109","author":"Mecucci","year":"2000","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/20\/2275\/1789199\/bloodbld2020007093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/20\/2275\/1789199\/bloodbld2020007093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T09:46:21Z","timestamp":1723369581000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/136\/20\/2275\/461761\/Mechanistic-insights-and-potential-therapeutic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":167,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020,11,12]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020007093","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]}}}